Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,583,122

« Back to Dashboard

Patent 5,583,122 protects ATELVIA, ACTONEL WITH CALCIUM (COPACKAGED), and ACTONEL, and is included in three NDAs. There have been zero Paragraph IV challenges on Atelvia and Actonel There are four tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

Protection for ATELVIA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,583,122

Title: Pharmaceutical compositions containing geminal diphosphonates
Abstract:Pharmaceutical compositions, useful for treating abnormal calcium and phosphate metabolism, which contain geminal-diphosphonic acid compounds; and a method of treating diseases characterized by abnormal calcium and phosphate metabolism utilizing these pharmaceutical compositions.
Inventor(s): Benedict; James J. (Norwich, NY), Perkins; Christopher M. (Cincinnati, OH)
Assignee: The Procter & Gamble Company (Cincinnati, OH)
Application Number:06/806,155
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Warner Chilcott Llc
ATELVIA
risedronate sodium
TABLET, DELAYED RELEASE;ORAL022560Oct 8, 2010RXYes5,583,122*PED<disabled>Y
Warner Chilcott
ACTONEL WITH CALCIUM (COPACKAGED)
calcium carbonate; risedronate sodium
TABLET, TABLET;ORAL021823Aug 12, 2005DISCNNo5,583,122*PED<disabled>Y
Warner Chilcott Llc
ACTONEL
risedronate sodium
TABLET;ORAL020835Apr 14, 2000RXNo5,583,122*PED<disabled>Y
Warner Chilcott Llc
ACTONEL
risedronate sodium
TABLET;ORAL020835Mar 27, 1998RXNo5,583,122*PED<disabled>Y
Warner Chilcott Llc
ACTONEL
risedronate sodium
TABLET;ORAL020835May 25, 2002RXYes5,583,122*PED<disabled>Y
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,583,122

Country Document Number Publication Date
South Africa8509694Aug 27, 1986
Philippines27078Feb 01, 1993
New Zealand214651Apr 26, 1990
Netherlands300031Feb 01, 2001
Luxembourg90669Jan 10, 2001
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc